Skip to main content
Fig. 7 | European Journal of Medical Research

Fig. 7

From: Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer

Fig. 7

KEGG pathway enrichment of candidate targets of triptonodiol against lung cancer. Pathways that had significant changes of FDR < 0.05 were identified. The size of the spot represents a number of genes and color represents FDR value. The most enriched pathways are shown in the ErbB signaling diagram on the right, with the top ten gene targets for screening marked by red boxes

Back to article page